Activation of p38 Mitogen-Activated Protein Kinase and c-Jun NH₂-Terminal Kinase by Double-Stranded RNA and Encephalomyocarditis Virus: Involvement of RNase L, Protein Kinase R, and Alternative Pathways

REFERENCES

• Baldassare, J. J., Bi, Y., and Bellone, C. J.. 1999. The role of p38 mitogen-activated protein kinase in IL-1 beta transcription. J. Immunol. 162:5367–5373
   PubMed Web of Science ®Google Scholar
• Beyaert, R., Cuenda, A., Vanden Berghe, W., Plaisance, S., Lee, J. C., Haegeman, G., Cohen, P., and Fiers, W.. 1996. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 15:1914–1923
   PubMed Web of Science ®Google Scholar
• Brimacombe, R.. 1995. The structure of ribosomal RNA: a three-dimensional jigsaw puzzle. Eur. J. Biochem. 230:365–383
   PubMedGoogle Scholar
• Cavigelli, M., Li, W. W., Lin, A., Su, B., Yoshioka, K., and Karin, M.. 1996. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J. 15:6269–6279
   PubMed Web of Science ®Google Scholar
• Chebath, J., Benech, P., Hovanessian, A., Galabru, J., and Revel, M.. 1987. Four different forms of interferon-induced 2′,5′-oligo(A) synthetase identified by immunoblotting in human cells. J. Biol. Chem. 262:3852–3857
   PubMed Web of Science ®Google Scholar
• Chen, C. Y., Del Gatto-Konczak, F., Wu, Z., and Karin, M.. 1998. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 280:1945–1949
   PubMed Web of Science ®Google Scholar
• Chen, Y. R., Wang, X., Templeton, D., Davis, R. J., and Tan, T. H.. 1996. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem. 271:31929–31936
   PubMed Web of Science ®Google Scholar
• Clemens, M. J.. 1997. PKR—a protein kinase regulated by double-stranded RNA. Int. J. Biochem. Cell Biol. 29:945–949
   PubMed Web of Science ®Google Scholar
• Clemens, M. J.. 1994. Regulation of eukaryotic protein synthesis by protein kinases that phosphorylate initiation factor eIF-2. Mol. Biol. Rep. 19:201–210
   PubMedGoogle Scholar
• Clemens, M. J., and Bommer, U. A.. 1999. Translational control: the cancer connection. Int. J. Biochem. Cell Biol. 31:1–23
   PubMedGoogle Scholar
• Clemens, M. J., and Elia, A.. 1997. The double-stranded RNA-dependent protein kinase PKR: structure and function. J. Interferon Cytokine Res. 17:503–524
   PubMed Web of Science ®Google Scholar
• Davis, R. J.. 1999. Signal transduction by the c-Jun N-terminal kinase. Biochem. Soc. Symp. 64:1–12
   PubMedGoogle Scholar
• Derijard, B., Raingeaud, J., Barrett, T., Wu, I. H., Han, J., Ulevitch, R. J., and Davis, R. J.. 1995. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682–685 (Erratum, 269:17.)
   PubMed Web of Science ®Google Scholar
• Dube, P., Bacher, G., Stark, H., Mueller, F., Zemlin, F., van Heel, M., and Brimacombe, R.. 1998. Correlation of the expansion segments in mammalian rRNA with the fine structure of the 80 S ribosome; a cryoelectron microscopic reconstruction of the rabbit reticulocyte ribosome at 21 A resolution. J. Mol. Biol. 279:403–421
   PubMedGoogle Scholar
• Galcheva-Gargova, Z., Derijard, B., Wu, I. H., and Davis, R. J.. 1994. An osmosensing signal transduction pathway in mammalian cells. Science 265:806–808
   PubMed Web of Science ®Google Scholar
• Gale, M.Jr., and Katze, M. G.. 1998. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol. Ther. 78:29–46
   PubMed Web of Science ®Google Scholar
• Gangemi, J. D., Matter, A., Poncioni, B., and Hochkeppel, H. K.. 1989. Significant differences in therapeutic responses to a human interferon-alpha B/D hybrid in Rauscher or Friend murine leukemia virus infections. J. Interferon Res. 9:275–283
   PubMedGoogle Scholar
• Garrington, T. P., and Johnson, G. L.. 1999. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11:211–218
   PubMed Web of Science ®Google Scholar
• Hambleton, J., Weinstein, S. L., Lem, L., and DeFranco, A. L.. 1996. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc. Natl. Acad. Sci. USA 93:2774–2778
   PubMed Web of Science ®Google Scholar
• Han, J., Lee, J. D., Bibbs, L., and Ulevitch, R. J.. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808–811
   PubMed Web of Science ®Google Scholar
• Han, J., Lee, J. D., Jiang, Y., Li, Z., Feng, L., and Ulevitch, R. J.. 1996. Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J. Biol. Chem. 271:2886–2891
   PubMed Web of Science ®Google Scholar
• Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin, M.. 1993. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:2135–2148
   PubMed Web of Science ®Google Scholar
• Iordanov, M., Bender, K., Ade, T., Schmid, W., Sachsenmaier, C., Engel, K., Gaestel, M., Rahmsdorf, H. J., and Herrlich, P.. 1997. CREB is activated by UVC through a p38/HOG-1-dependent protein kinase. EMBO J. 16:1009–1022
   PubMedGoogle Scholar
• Iordanov, M. S., and Magun, B. E.. 1998. Loss of cellular K+ mimics ribotoxic stress. Inhibition of protein synthesis and activation of the stress kinases SEK1/MKK4, stress-activated protein kinase/c-Jun NH2-terminal kinase 1, and p38/HOG1 by palytoxin. J. Biol. Chem. 273:3528–3534
   PubMed Web of Science ®Google Scholar
• Iordanov, M. S., Pribnow, D., Magun, J. L., Dinh, T. H., Pearson, J. A., Chen, S. L., and Magun, B. E.. 1997. Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the α-sarcin/ricin loop in the 28S rRNA. Mol. Cell. Biol. 17:3373–3381
   PubMed Web of Science ®Google Scholar
• Iordanov, M. S., Pribnow, D., Magun, J. L., Dinh, T. H., Pearson, J. A., and Magun, B. E.. 1998. Ultraviolet radiation triggers the ribotoxic stress response in mammalian cells. J. Biol. Chem. 273:15794–15803
   PubMed Web of Science ®Google Scholar
• Ip, Y. T., and Davis, R. J.. 1998. Signal transduction by the c-Jun N-terminal kinase (JNK)—from inflammation to development. Curr. Opin. Cell Biol. 10:205–219
   PubMed Web of Science ®Google Scholar
• Iwasaki, A., Matsumori, A., Yamada, T., Shioi, T., Wang, W., Ono, K., Nishio, R., Okada, M., and Sasayama, S.. 1999. Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis. J. Am. Coll. Cardiol. 33:1400–1407
   PubMed Web of Science ®Google Scholar
• Jackson, J. R., Bolognese, B., Hillegass, L., Kassis, S., Adams, J., Griswold, D. E., and Winkler, J. D.. 1998. Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. J. Pharmacol. Exp. Ther. 284:687–692
   PubMed Web of Science ®Google Scholar
• Jagus, R., Joshi, B., and Barber, G. N.. 1999. PKR, apoptosis and cancer. Int. J. Biochem. Cell Biol. 31:123–138
   PubMedGoogle Scholar
• Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A., and Green, D. R.. 1998. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Mol. Cell 1:543–551
   PubMed Web of Science ®Google Scholar
• Kerr, I. M., and Brown, R. E.. 1978. pppA2′p5′A2′p5′A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc. Natl. Acad. Sci. USA 75:256–260
   PubMed Web of Science ®Google Scholar
• Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., and Kohler, G.. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339–342
   PubMed Web of Science ®Google Scholar
• Kotlyarov, A., Neininger, A., Schubert, C., Eckert, R., Birchmeier, C., Volk, H.-D., and Gaestel, M.. 1999. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat. Cell Biol. 1:94–97
   PubMed Web of Science ®Google Scholar
• Koyama, A. H., Arakawa, T., and Adachi, A.. 1998. Acceleration of virus-induced apoptosis by tumor necrosis factor. FEBS Lett. 426:179–182
   PubMedGoogle Scholar
• Krause, A., Holtmann, H., Eickemeier, S., Winzen, R., Szamel, M., Resch, K., Saklatvala, J., and Kracht, M.. 1998. Stress-activated protein kinase/Jun N-terminal kinase is required for interleukin (IL)-1-induced IL-6 and IL-8 gene expression in the human epidermal carcinoma cell line KB. J. Biol. Chem. 273:23681–23689
   PubMed Web of Science ®Google Scholar
• Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Heys, J. R., Landvatter, S. W. et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739–746
   PubMed Web of Science ®Google Scholar
• Le-Niculescu, H., Bonfoco, E., Kasuya, Y., Claret, F. X., Green, D. R., and Karin, M.. 1999. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol. Cell. Biol. 19:751–763
   PubMed Web of Science ®Google Scholar
• Levin, D., and London, I. M.. 1978. Regulation of protein synthesis: activation by double-stranded RNA of a protein kinase that phosphorylates eukaryotic initiation factor 2. Proc. Natl. Acad. Sci. USA 75:1121–1125
   PubMed Web of Science ®Google Scholar
• Liu, Y., Gorospe, M., Yang, C., and Holbrook, N. J.. 1995. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun N-terminal kinase activity and AP-1-dependent gene activation. J. Biol. Chem. 270:8377–8380
   PubMed Web of Science ®Google Scholar
• Meriin, A. B., Yaglom, J. A., Gabai, V. L., Zon, L., Ganiatsas, S., Mosser, D. D., Zon, L., and Sherman, M. Y.. 1999. Protein-damaging stresses activate c-Jun N-terminal kinase via inhibition of its dephosphorylation: a novel pathway controlled by HSP72. Mol. Cell. Biol. 19:2547–2555 (Erratum, 19:5235.)
   PubMed Web of Science ®Google Scholar
• Meurs, E., Chong, K., Galabru, J., Thomas, N. S., Kerr, I. M., Williams, B. R., and Hovanessian, A. G.. 1990. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62:379–390
   PubMed Web of Science ®Google Scholar
• Miyazawa, K., Mori, A., Miyata, H., Akahane, M., Ajisawa, Y., and Okudaira, H.. 1998. Regulation of interleukin-1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase. J. Biol. Chem. 273:24832–24838
   PubMed Web of Science ®Google Scholar
• Nagata, Y., and Todokoro, K.. 1999. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood 94:853–863
   PubMed Web of Science ®Google Scholar
• Pandey, P., Raingeaud, J., Kaneki, M., Weichselbaum, R., Davis, R. J., Kufe, D., and Kharbanda, S.. 1996. Activation of p38 mitogen-activated protein kinase by c-Abl-dependent and -independent mechanisms. J. Biol. Chem. 271:23775–23779
   PubMedGoogle Scholar
• Player, M. R., and Torrence, P. F.. 1998. The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation. Pharmacol. Ther. 78:55–113
   PubMed Web of Science ®Google Scholar
• Proud, C. G.. 1995. PKR: a new name and new roles. Trends Biochem. Sci. 20:241–246
   PubMed Web of Science ®Google Scholar
• Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., and Davis, R. J.. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270:7420–7426
   PubMed Web of Science ®Google Scholar
• Rincon, M., Enslen, H., Raingeaud, J., Recht, M., Zapton, T., Su, M. S., Penix, L. A., Davis, R. J., and Flavell, R. A.. 1998. Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 17:2817–2829
   PubMed Web of Science ®Google Scholar
• Schaeffer, H. J., and Weber, M. J.. 1999. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19:2435–2444
   PubMed Web of Science ®Google Scholar
• Shifrin, V. I., and Anderson, P.. 1999. Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. J. Biol. Chem. 274:13985–13992
   PubMed Web of Science ®Google Scholar
• Shioi, T., Matsumori, A., and Sasayama, S.. 1996. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation 94:2930–2939
   PubMed Web of Science ®Google Scholar
• Silverman, R. H.. 1997. 2-5A dependent RNase L: a regulated endoribonuclease in the interferon system Ribonucleases: structures and functions. Riordan, J. F., and D'Alessio, G. 515–551 Academic Press, Inc., San Diego, Calif
   Google Scholar
• Silverman, R. H., Cayley, P. J., Knight, M., Gilbert, C. S., and Kerr, I. M.. 1982. Control of the ppp(a2′p)nA system in HeLa cells. Effects of interferon and virus infection. Eur. J. Biochem. 124:131–138
   PubMedGoogle Scholar
• Silverman, R. H., Skehel, J. J., James, T. C., Wreschner, D. H., and Kerr, I. M.. 1983. rRNA cleavage as an index of ppp(A2′p)nA activity in interferon-treated encephalomyocarditis virus-infected cells. J. Virol. 46:1051–1055
   PubMed Web of Science ®Google Scholar
• Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H., and Schreiber, R. D.. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227–264
   PubMed Web of Science ®Google Scholar
• Su, B., Jacinto, E., Hibi, M., Kallunki, T., Karin, M., and Ben-Neriah, Y.. 1994. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77:727–736
   PubMed Web of Science ®Google Scholar
• Sun, H., Charles, C. H., Lau, L. F., and Tonks, N. K.. 1993. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75:487–493
   PubMed Web of Science ®Google Scholar
• Tournier, C., Whitmarsh, A. J., Cavanagh, J., Barrett, T., and Davis, R. J.. 1997. Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. Proc. Natl. Acad. Sci. USA 94:7337–7342
   PubMed Web of Science ®Google Scholar
• Westwick, J. K., Weitzel, C., Minden, A., Karin, M., and Brenner, D. A.. 1994. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J. Biol. Chem. 269:26396–26401
   PubMed Web of Science ®Google Scholar
• Williams, B. R.. 1997. Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation. Biochem. Soc. Trans. 25:509–513
   PubMed Web of Science ®Google Scholar
• Wreschner, D. H., James, T. C., Silverman, R. H., and Kerr, I. M.. 1981. Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2′p)nA) in interferon-treated cells. Nucleic Acids Res. 9:1571–1581
   PubMed Web of Science ®Google Scholar
• Wysk, M., Yang, D. D., Lu, H. T., Flavell, R. A., and Davis, R. J.. 1999. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression. Proc. Natl. Acad. Sci. USA 96:3763–3768
   PubMed Web of Science ®Google Scholar
• Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., and Greenberg, M. E.. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326–1331
   PubMed Web of Science ®Google Scholar
• Zhou, A., Hassel, B. A., and Silverman, R. H.. 1993. Expression cloning of 2-5A-dependent RNase: a uniquely regulated mediator of interferon action. Cell 72:753–765
   PubMed Web of Science ®Google Scholar
• Zhou, A., Paranjape, J. M., Der, S. D., Williams, B. R., and Silverman, R. H.. 1999. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 258:435–440
   PubMed Web of Science ®Google Scholar
• Zhou, A., Paranjape, J. M., Hassel, B. A., Nie, H., Shah, S., Galinski, B., and Silverman, R. H.. 1998. Impact of RNase L overexpression on viral and cellular growth and death. J. Interferon Cytokine Res. 18:953–961
   PubMedGoogle Scholar